Navigation Links
Accumetrics, Inc. Announces Distribution Channels in Israel and Cyprus
Date:6/9/2009

SAN DIEGO, June 9 /PRNewswire/ -- Accumetrics, Inc. announces today it has signed new distribution agreements for its VerifyNow(R) System in both Israel and Cyprus. Medtechnica, Ltd. will oversee distribution of all VerifyNow products in Israel, while Z.S. Curemed, Ltd. will be the sole distribution channel in Cyprus. These distribution agreements continue to expand Accumetrics' reach in both scope and geography, and add to the growing numbers of countries outside of the United States and Europe where physicians have access to the VerifyNow System.

The VerifyNow System assesses response to antiplatelet therapies, such as aspirin, Plavix(R) and GP IIb/IIIa inhibitors. As response to these drugs varies, the tests help physicians ensure their patients on antiplatelet medications are receiving the optimal benefit.

"We're extremely excited to see distribution of our VerifyNow System reach Israel and Cyprus. We have chosen these partners based on their demonstrated expertise and knowledge of our markets in their respective territories," said Timothy I. Still, President and CEO of Accumetrics. "These partnerships continue to emphasize our focus on expanding our global distribution channels, and support our vision of providing physicians worldwide access to critical information for managing their cardiovascular patients on antiplatelet therapies."

About Accumetrics (www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including EC-cleared product for prasugrel and FDA-cleared products for aspirin, Plavix, ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of sanofi-aventis.

About Medtechnica, Ltd.

Founded in 1958, Medtechnica, Ltd. has become one of the largest medical equipment suppliers in Israel. Medtechnica is the sole distributor, in Israel, of leading international manufacturers of medical equipment, including Phillips Medical Systems, Olympus Medical, Maquet, 3M Medical and among others.

About Z.S. Curemed, Ltd.

Established in 2001 in Cyprus, Curemed has grown to become one of the leading companies in the sectors of Interventional Cardiology and Intensive Care. Curemed focuses on promotion, sales and support of innovative Interventional Cardiology and Intensive Care devices to Public and Private Hospitals in Cyprus. Curemed conforms to EN ISO 9001: 2008.

    CONTACT:
    Jules Abraham
    Lippert/Heilshorn & Associates
    212-838-3777
    jabraham@lhai.com

    Timothy I. Still
    President and CEO
    Accumetrics
    press@accumetrics.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial
2. Accumetrics, Inc. Announces United Kingdom Distribution Agreement With ELITech UK Limited
3. Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
4. Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.
5. Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
6. Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit
7. Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors
8. Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging
9. Life Spine Announces Appointment of Todd Fanning as Vice President of Sales
10. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
11. ThinIdentity(TM) Announces Two New Board Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... TX (PRWEB) , ... December 08, 2016 , ... STAT ... continue to be a convenient service for Texas, they are expanding their presence in ... involve a hiring spree that will bring new jobs to the Dallas and Forth ...
(Date:12/8/2016)... Francisco, California (PRWEB) , ... December 08, 2016 , ... ... coaches, has raised an $18M Series B led by Canvas Ventures . Other ... the capital to scale its mobile platform to serve more consumers who are managing ...
(Date:12/8/2016)... ... 08, 2016 , ... Peter Zipp Insurance, an Arizona-based insurance ... greater Phoenix metropolitan region, is announcing a charity event to provide support and ... Youth Connection is to promote community awareness of the ongoing needs of at-risk ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... services to families and business owners in and around central Kansas, is joining ... to at-risk youth in the region. , Headquartered in Wichita, Youth Horizons works ...
(Date:12/7/2016)... Wisconsin (PRWEB) , ... December 07, 2016 , ... Kenall ... extraordinary new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire ... right amount of light where and when it’s needed. , A 2’ ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
(Date:12/8/2016)... PUNE, India , December 8, 2016 According ... (Diagnostic (Heart, Pulse, BP, Sleep, Fetal), Therapeutic (Pain, Insulin)), End Use (Sports, ... to 2021", published by MarketsandMarkets, the global market, in terms of value, ... in 2016, at a CAGR of 18.0% during the forecast period. ... ...
(Date:12/8/2016)... 8, 2016  Haemonetics Corporation (NYSE: HAE ) ... System), an innovative software suite designed to help customers drive ... launch of NextGen DMS 4 improves core features and introduces ... per liter of plasma collected, enhancing quality and regulatory compliance ... ...
Breaking Medicine Technology: